Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Edwards

Showing results (81-90 of 158) with videos related to

Pageof 16
Sort By:
Gynecologic Oncology|September 1, 1990
Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer: a preliminary analysisC A Stringer, D M Gershenson, T W Burke, et al.
Obstetrics and Gynecology|December 1, 1983
Immunotherapy for vulvar carcinoma with virus-modified homologous extractsR S Freedman, J M Bowen, J H Herson, et al.
Obstetrics and Gynecology|June 1, 1986
Second-look laparotomy in the management of malignant germ cell tumors of the ovaryD M Gershenson, L J Copeland, G del Junco, et al.
Anti-Cancer Drugs|June 13, 1998
Prolonged remission of endometrial cancer with paclitaxel and carboplatinA Vasuratna, A P Kudelka, C L Edwards, et al.
American Journal of Obstetrics and Gynecology|May 1, 1989
Gracilis myocutaneous vaginal reconstruction concurrent with total pelvic exenterationL J Copeland, K C Hancock, D M Gershenson, et al.
Journal of Immunological Methods|January 3, 1994
Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapyR S Freedman, B Tomasovic, S Templin, et al.
Gynecologic Oncology|January 1, 1993
Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapyH O Smith, C A Stringer, J J Kavanagh, et al.
Gynecologic Oncology|June 1, 1984
An ultrastructural comparison of grade I and II endometrial adenocarcinoma considering estrogen and progesterone receptor statusD V Horbelt, R S Freedman, D K Roberts, et al.
European Journal of Gynaecological Oncology|January 1, 1996
Two synchronous primary tumors of the ovary and kidney: a case reportO Balat, A P Kudelka, J Y Ro, et al.
Clinical and Experimental Dermatology|October 3, 2020
Cutaneous toxicities in patients with melanoma receiving checkpoint inhibitor therapy: a retrospective review. The experience of a single large specialist institutionC L Edwards, F Comito, S Agraso Busto, et al.
Pageof 16

Showing results (81-90 of 158) with videos related to

Sort By:
Pageof 16
Gynecologic Oncology|September 1, 1990
Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer: a preliminary analysisC A Stringer, D M Gershenson, T W Burke, et al.
Obstetrics and Gynecology|December 1, 1983
Immunotherapy for vulvar carcinoma with virus-modified homologous extractsR S Freedman, J M Bowen, J H Herson, et al.
Obstetrics and Gynecology|June 1, 1986
Second-look laparotomy in the management of malignant germ cell tumors of the ovaryD M Gershenson, L J Copeland, G del Junco, et al.
Anti-Cancer Drugs|June 13, 1998
Prolonged remission of endometrial cancer with paclitaxel and carboplatinA Vasuratna, A P Kudelka, C L Edwards, et al.
American Journal of Obstetrics and Gynecology|May 1, 1989
Gracilis myocutaneous vaginal reconstruction concurrent with total pelvic exenterationL J Copeland, K C Hancock, D M Gershenson, et al.
Journal of Immunological Methods|January 3, 1994
Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapyR S Freedman, B Tomasovic, S Templin, et al.
Gynecologic Oncology|January 1, 1993
Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapyH O Smith, C A Stringer, J J Kavanagh, et al.
Gynecologic Oncology|June 1, 1984
An ultrastructural comparison of grade I and II endometrial adenocarcinoma considering estrogen and progesterone receptor statusD V Horbelt, R S Freedman, D K Roberts, et al.
European Journal of Gynaecological Oncology|January 1, 1996
Two synchronous primary tumors of the ovary and kidney: a case reportO Balat, A P Kudelka, J Y Ro, et al.
Clinical and Experimental Dermatology|October 3, 2020
Cutaneous toxicities in patients with melanoma receiving checkpoint inhibitor therapy: a retrospective review. The experience of a single large specialist institutionC L Edwards, F Comito, S Agraso Busto, et al.
Pageof 16